Similarly, 16 of the 85 NF1-M members located at chromosome 10 were lost at similar frequencies as the loss of PTEN-M members in the RMPAhigh gliomas, resulting in gene dosage-dependent down-regulation of expression with a significant potential to influence the expression level of the entire NF1-M. The gene discussed is PTEN; the disease is central nervous system cancer.